Catalyst Wire Dossier Catalyst Wire Dossier

XH-S004

XH-S004 · S-INFINITY Pharmaceuticals Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XH-S004, covering 2025-05-20 to 2025-05-20. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis [Phase 2]

See pricing